mitral failure | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20,357 results for “mitral failure”

Trials

View all 16739 →

PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients

72 participants · First posted Feb 20, 2018

Not yet recruiting

Mitral Valve Edge-to-Edge Repair in Patients With Exercise-Induced Severe Mitral Regurgitation

246 participants · First posted Jul 16, 2026

NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation

32 participants · First posted Jan 9, 2017

Drugs

View all 244 →

Heart Failure(River Biomedics)

nanoparticle therapeutics (heart failure)

RXFP1 agonist (heart failure)

Organizations

View all 36 →

VentriPoint Diagnostics Ltd

scPharmaceuticals

United States

Lexicon Pharmaceuticals

United States

News

View all 3338 →

Affluent Medical Advances Three Medical Device Programs with Pivotal Trial Launch and FDA Regulatory Progress

MATTERHORN Trial: TEER Non-Inferior to Surgery for Secondary Mitral Regurgitation

Medtronic and Tempus Launch Study to Address Disparities in Structural Heart Disease Treatment

Page 1 of 2036